ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,214.08
0.51%
US Tech 100
17,724.00
0.47%
다우존스 지수
39,387.76
0.85%
Bitcoin
63,002.42
-0.07%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Achieve Life Sciences Inc (ACHV)

  7. Achieve Life Sciences Inc (ACHV) 뉴스

ACHV

Achieve Life Sciences (ACHV)

Achieve Life Sciences Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACHV
일자시간출처헤드라인심볼기업
2024/05/1005:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
2024/05/1005:01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
2024/05/0713:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACHVAchieve Life Sciences Inc
2024/05/0700:16GlobeNewswire Inc.Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal MedicineNASDAQ:ACHVAchieve Life Sciences Inc
2024/04/2521:00GlobeNewswire Inc.Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 9, 2024NASDAQ:ACHVAchieve Life Sciences Inc
2024/04/1121:00GlobeNewswire Inc.Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 ConferenceNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/2905:01GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/2021:00GlobeNewswire Inc.Achieve Life Sciences Announces Data from Cytisinicline ORCA Program to be Presented at the 2024 Society for Research on Nicotine and Tobacco (SRNT) Annual MeetingNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/1421:00GlobeNewswire Inc.Achieve Life Sciences to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call and Webcast on March 28, 2024NASDAQ:ACHVAchieve Life Sciences Inc
2024/03/0706:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/0706:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/0106:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
2024/03/0106:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACHVAchieve Life Sciences Inc
2024/02/2922:01GlobeNewswire Inc.Achieve Life Sciences Reaches Agreement with the FDA on Long-Term Cytisinicline Exposure Data Requirements for NDA SubmissionNASDAQ:ACHVAchieve Life Sciences Inc
2024/02/2922:00GlobeNewswire Inc.Achieve Life Sciences Announces Pricing of up to $124.2 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:ACHVAchieve Life Sciences Inc
2024/02/2805:32Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/3004:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2509:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2508:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2024/01/2508:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ACHVAchieve Life Sciences Inc
2023/12/1206:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACHVAchieve Life Sciences Inc
2023/11/1006:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACHVAchieve Life Sciences Inc
2023/11/1006:00GlobeNewswire Inc.Achieve Life Sciences Reports Financial Results for Third Quarter and Provides Corporate UpdateNASDAQ:ACHVAchieve Life Sciences Inc
2023/10/2621:00GlobeNewswire Inc.Achieve Life Sciences to Announce Third Quarter 2023 Financial Results and Host Conference Call and Webcast on November 9, 2023NASDAQ:ACHVAchieve Life Sciences Inc
2023/10/0321:00GlobeNewswire Inc.Achieve Life Sciences Announces Participation at Upcoming Investor ConferencesNASDAQ:ACHVAchieve Life Sciences Inc
 검색 관련기사 보기:NASDAQ:ACHV

최근 히스토리

NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLF
Financial Select Sector
CCOM
US30
US 30
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NYSE
CVX
Chevron
USI
USTECH100
US Tech 100
CCOM
SILVER
SILVER
NASDAQ
AMZN
Amazon.com
AMEX
XLE
Energy Select Sector SPDR
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
USOTC
BASFY
BASF (QX)
NYSE
KO
Coca Cola
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유